Navigating the Regulatory Landscape with Confidence: The Medicorum Compliance-First Framework
The decision to form a micro-captive insurance company must begin with a clear and candid understanding of the regulatory environment. For over a decade, the Internal Revenue Service (IRS) has identified certain micro-captive arrangements, particularly those electing taxation under IRC §831(b), as having the potential for tax abuse. These arrangements have been featured on the IRS's "Dirty Dozen" list of tax scams, and the agency has successfully challenged improperly structured captives in court.
This history of intense scrutiny is not a deterrent; it is the foundation of our methodology. The era of regulatory ambiguity has ended. The IRS's issuance of the 2025 Final Regulations (T.D. 10029) has replaced vague guidelines with a clear, rules-based framework for compliance. At Medicorum Wealth Management, our research and advisory services are built not to circumvent these rules, but to engineer structures that are fully compliant with them from inception. We believe that demonstrating an exhaustive understanding of and adherence to these regulations is the ultimate source of security and strength for our clients.
The 2025 Final Regulations represent a pivotal shift. They move the classification of micro-captive transactions from IRS "Notices," which courts found to be unenforceable without public comment, to the status of binding federal regulations. These rules establish two categories of reportable transactions based on objective, data-driven tests.
This is a disclosure category. An 831(b) micro-captive arrangement is deemed a "Transaction of Interest" if it meets either of two specific tests: the Financing Factor or the Loss Ratio Factor.
This classification requires the participants to file a disclosure statement (Form 8886) with the IRS, alerting the agency to the transaction's existence.
It does not carry a presumption of being abusive, but it does increase the likelihood of scrutiny.
This is a more severe classification, reserved for transactions the IRS presumes to be abusive.
An 831(b) micro-captive arrangement is deemed a "Listed Transaction" only if it meets both the Financing Factor and a more stringent version of the Loss Ratio Factor.
This classification carries the same disclosure requirement but is accompanied by a high probability of audit and significant potential penalties if the claimed tax benefits are disallowed.
The introduction of these bright-line numerical tests is a positive development for well-advised taxpayers. Compliance is no longer a matter of subjective interpretation but of measurable engineering. It allows a firm like Medicorum to build a provably compliant structure from the ground up.
The loss ratio is the primary metric the IRS uses to determine if a captive is operating like a real insurance company. A legitimate insurer expects to pay out a reasonable portion of the premiums it collects as claims over time.
The Formula:
The Thresholds:
Work with independent actuaries to design a balanced portfolio of insurance policies for the captive. This includes not only low-frequency, high-severity risks but also policies for risks with more frequent, smaller claims. This balanced approach should produce a sustainable, long-term loss ratio that is projected to remain comfortably above the 60% threshold, thereby avoiding reportable transaction status based on this factor.
The IRS is intensely focused on preventing what it calls a "circular flow of funds," where money is deducted as a premium, received tax-free by the captive, and then loaned or transferred back to the business owner without being taxed.
The governance documents for captive structures must contain strict prohibitions against any such related-party financing to neutralize the Financing Factor as a source of regulatory risk.
The IRS's current regulations are built upon the lessons learned from years of litigation. Tax Court cases, such as Avrahami v. Commissioner, Syzygy Insurance. Co. v. Commissioner, and Swift v. Commissioner provide a clear judicial roadmap of what constitutes a non-compliant captive.19 The courts have consistently ruled against arrangements that:
Your captive framework should incorporate these judicial "red flags" as a foundational checklist of practices to avoid, ensuring that every structure is built not only to the letter of the new regulations but also in the spirit of established case law.
Copyright © 2024 Medicorum Wealth Management, LLC - All Rights Reserved.